控制不良喘患者的IL-33受体抑制:一个随机的,安慰剂控制的试验
Courtney Crim1, Sally Stone2, Valerie Millar2
1Research and Development, GSK, Research Triangle Park, NC.
The journal of allergy and clinical immunology. Global
|October 2, 2023
概括
作为IL-33受体抑制剂的GSK3772847对严重的失控喘显示出潜在的益处. 需要进一步的研究来证实它在治疗这种疾病中的有效性和安全性.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 目前的严重喘生物药主要向2型免疫.
- 干白素-33 (IL-33) 信号抑制提供了一个潜在的策略,以解决喘中的2型和非2型炎症途径.
研究的目的:
- 评估GSK3772847的安全性和有效性,GSK3772847是一种向IL-33受体 (IL-33R) 的单克隆抗体.
- 评估GSK3772847在中度至重度未控制喘的成年患者中.
主要方法:
- 一个多中心的IIA期研究,涉及在标准治疗中患有失控喘的成年人.
- 参与者接受了静脉注射GSK3772847或安慰剂,并逐步减少了背景吸入性皮质类固醇/长效β2agonist治疗.
- 主要终点是失去喘控制;次要终点包括疗效,安全性,耐受性,药理动力学和药理动力学.
主要成果:
- 与安慰剂相比,在GSK3772847组观察到喘控制损失的统计显著减少 (18%的减少).
- 喘控制的早期丧失限制了在第4周以后对二次疗效终点的分析.
- 与治疗相关的不良事件在各组之间是可比的,心脏和肌肉骨/连接组织疾病最常见.
结论:
- GSK3772847在患有失控喘的患者中显示出潜在的治疗益处.
- 证实了IL-33受体的向参与.
- 需要进一步的临床研究来充分确定GSK3772847在喘管理中的作用.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
326
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
326
01:19Antiasthma Drugs: Leukotriene Modifiers
338
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
338
01:17Drugs Used in Lower Respiratory Disorders: Overview
474
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
474
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
289
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
289
01:26Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
290
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
290